Trials / Unknown
UnknownNCT03948399
The Prevalence of a Low Ankle-Brachial Index in Acute Cerebral Ischemia.
The Prevalence of a Low Ankle-Brachial Index in Patients With Acute Cerebral Ischemic Event.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Jan Biziel University Hospital No 2 in Bydgoszcz · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is assessment the prevalence of the low ankle-brachial index (ABI) defined less than or equal 0.9 in patients with acute cerebral ischemic event (stroke or transient ischemic attack) and determinate the correlation between ABI and internal carotid artery stenosis (ICAS) in the acute cerebral ischemic patients. The low ABI is a strong marker of generalized atherosclerosis. LEAD is a strong independent predictor for stroke.
Detailed description
Aim of the study is assessment the prevalence of the low ankle-brachial index (ABI) defined less than or equal 0.9 in patients with acute cerebral ischemic event (stroke or transient ischemic attack) and determinate the correlation between ABI and internal carotid artery stenosis (ICAS) in the acute cerebral ischemic patients. The ABI is a non-invasive tool useful for the diagnosis of LEAD. The low ABI is a strong marker of generalized atherosclerosis. LEAD is a strong independent predictor for stroke. Significant ICAS is prevalent among patients having LEAD. Acute ischemic stroke due to significant ICAS has poor prognosis. Patients with LEAD may be a suitable subgroup for screening for ICAS using duplex scanning. Estimating the relationship between cerebral ischemic event and the ABI value could help better guide preventive and risk reduction strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Duplex scanning of carotid arteries | Measurement of carotid arteries |
| DEVICE | ABI measurement | ankle brachial index (ABI) assessment |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Completion
- 2020-12-31
- First posted
- 2019-05-13
- Last updated
- 2019-05-13
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03948399. Inclusion in this directory is not an endorsement.